API Department (Quality Assessment)
PT
EN
Assessment policy
CADIFA Guidance
Impurities
ANVISA Guidelines
Other Guidelines
Pharmacopoeias
ANVISA links
Other links
FAQ
History
ICH
All Guidelines
CTD
Q Guidelines
M Guidelines
S Guidelines
E Guidelines
M4Q (CTD - Quality)
Q1A(R2)
Q1B
Q1D
Q1E
Q2(R1)
Q3A(R2)
Q3B(R2)
Q3C(R6)
Q3D(R1)
Q6A
Q6A (Decision trees)
Q7
ICH Q8(R2)
ICH Q9
ICH Q10
Q11
Q11 (P&R)
M7(R1)
Guidelines
Quality
Revision/Renewal of CEPs
Suspension and Withdrawal of CEPs
ICH Q3D & CEP
How to read a CEP
Guidelines
TRS 970 Annex 4 (Quality)
TRS 981 Annex 3
Amendments to APIMFs
ICH Q3D & APIMFs
EMA
Guidelines
Chemistry of active substances
ASMF Procedure
Variations (2013/C 223/01)
Stability testing for variations to a MA
Residual solvents (Annexes)
Specifications for related impurities in antibiotics.
QP declaration template
Sterilisation
Guidelines
ANDAs: Pharmaceutical Solid Polymorphism
Post-approval Changes to Drug Substances
Health Canada
Quality
Post‐Notice of Compliance